Peter O'Neill
Examiner · DISC type csAs Vice President of Clinical Operations at TuHURA Biosciences, Peter leverages over 25 years of leadership in oncology clinical trials. He excels at transforming complex operations into patient-focused processes and is a former cancer survivor himself. He holds an MBA from St. Josephs University and certificates from Wharton and Harvard Business School.
Peter is a passionate advocate for developing advanced immunotherapies, driven by his personal experience and his motto: "Work Hard, Stay Calm, and Cure Cancer. " He is also deeply involved in raising awareness and research funding for Angelman Syndrome, a rare neuro-genetic disorder that has personally affected his family.
Interesting fact: In 2020, Pharmaceutical Executive recognized him as an "Emerging Pharma Leader" for his contributions to the life sciences industry.
Read the full overview →How Peter shows up
They are heavily focused on quality and prefer doing things the right way, even if it takes time. They do not like taking risks at all and go for proven options in the end. Being observant comes to them naturally.
Topics Peter cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.